Reagent Kit for the Detection of Total Antibodies to SARS-CoV-2 (COVID-19) by Enzyme-Linked Immunosorbent Assay (“DS-ELISA-ANTI-SARS-CoV-2-TOTAL ANTIBODIES”), TU 21.20.23-242-05941003-2020, Series: 242001, 242002

The reagent kit is designed to detect total antibodies to the SARS-CoV-2 (COVID-19) virus using the enzyme-linked immunosorbent assay (ELISA) method.

Series: 242001, 242002

Immunosorbent: 96-well polystyrene microplate, detachable into strips or individual wells, pre-coated with a recombinant SARS-CoV-2 antigen – ready to use: 1 plate
Conjugate: recombinant SARS-CoV-2 antigen labeled with horseradish peroxidase – ready to use: 1 vial, 10.0 ml
Positive control (K+): inactivated, ready to use: 1 vial, 0.5 ml
Negative control (K-): inactivated, ready to use: 1 vial, 1.0 ml
Wash buffer (PR): phosphate-buffered saline with Tween (PBS-T), 25× concentrate – 1 vial, 50.0 ml
Stop reagent: 0.2M sulfuric acid solution – ready to use: 1 vial, 25.0 ml
Substrate buffer (SB): nitrate buffer containing hydrogen peroxide solution – ready to use: 1 vial, 25.0 ml
TMB substrate (TMB): 11× concentrate of 3,3′,5,5′-tetramethylbenzidine solution – 1 vial, 2.5 ml
Protective film for ELISA plates: 2 pieces
Disposable pipette tips: 16 pieces
Plastic reagent trays: 2 pieces
Zip-lock polyethylene bag: 1 piece
Instructions for use: 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for the Detection of Total Antibodies to SARS-CoV-2 (COVID-19) by Enzyme-Linked Immunosorbent Assay (“DS-ELISA-ANTI-SARS-CoV-2-TOTAL ANTIBODIES”), TU 21.20.23-242-05941003-2020, Series: 242001, 242002, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back